Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 4/2011

01.12.2011 | Review Article

Friedreich’s Ataxia: a review from a cardiology perspective

verfasst von: T. Bourke, D. Keane

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Neuromuscular disorders are not among the common causes of cardiomyopathy in the general population; however, cardiomyopathy is known to occur in several neuromuscular disorders including Friedreich’s Ataxia (FA). In patients with neuromuscular disorders, concomitant cardiac involvement contributes significantly to morbidity and mortality and often leads to premature death.

Methods

An extensive literature search of Medline and Pubmed was conducted to include all published reports on cardiac involvement in FA. Secondary articles were identified from key paper reference listings.

Conclusion

Hypertrophic cardiomyopathy is a cardinal feature of FA; therefore all FA patients should be screened for cardiomyopathy. A cardiac examination, ECG and ECHO are advised at diagnosis, and also on the development of any cardiac symptoms. Treatment is determined by the presence of symptoms, the presence of left ventricular outflow gradient and the sudden death risk. Institution of aggressive medical therapy early in the course of the disease may help improve quality of life and provide survival benefit.
Literatur
1.
Zurück zum Zitat Chamberlain S, Shaw J, Rowland A et al (1988) Mapping of mutation causing Friedreich’s ataxia to human chromosome 9. Nature 334(6179):248–250PubMedCrossRef Chamberlain S, Shaw J, Rowland A et al (1988) Mapping of mutation causing Friedreich’s ataxia to human chromosome 9. Nature 334(6179):248–250PubMedCrossRef
2.
Zurück zum Zitat Delatycki MB, Williamson R, SM Forrest (2000) Friedreich ataxia: an overview. J Med Genet 37(1):1–8 Delatycki MB, Williamson R, SM Forrest (2000) Friedreich ataxia: an overview. J Med Genet 37(1):1–8
3.
Zurück zum Zitat Child JS, Perloff JK, Bach PM, Wolfe AD, Perlman S, Kark RA (1986) Cardiac involvement in Friedreich’s ataxia: a clinical study of 75 patients. J Am Coll Cardiol 7(6):1370–1378PubMedCrossRef Child JS, Perloff JK, Bach PM, Wolfe AD, Perlman S, Kark RA (1986) Cardiac involvement in Friedreich’s ataxia: a clinical study of 75 patients. J Am Coll Cardiol 7(6):1370–1378PubMedCrossRef
4.
Zurück zum Zitat Lewis WR, Yadlapalli S (1998) Management of cardiac complications in neuromuscular disease. Phys Med Rehabil Clin N Am 9(1):145–66, vii Lewis WR, Yadlapalli S (1998) Management of cardiac complications in neuromuscular disease. Phys Med Rehabil Clin N Am 9(1):145–66, vii
5.
Zurück zum Zitat Harding AE (1981) Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104(3):589–620PubMedCrossRef Harding AE (1981) Friedreich’s ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain 104(3):589–620PubMedCrossRef
6.
Zurück zum Zitat De Michele GPF (1996) Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich’s disease: a retrospective study on 119 patients. Neurology 47:1260–1264PubMed De Michele GPF (1996) Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich’s disease: a retrospective study on 119 patients. Neurology 47:1260–1264PubMed
7.
Zurück zum Zitat Filla A, DeMichele G, Caruso G, Marconi R, Campanella G (1990) Genetic data and natural history of Friedreich’s disease: a study of 80 Italian patients. J Neurol 237(6):345–351PubMedCrossRef Filla A, DeMichele G, Caruso G, Marconi R, Campanella G (1990) Genetic data and natural history of Friedreich’s disease: a study of 80 Italian patients. J Neurol 237(6):345–351PubMedCrossRef
8.
Zurück zum Zitat Casazza F, Ferrari F, Piccone U, Maggiolini S, Capozi A, Morpurgo M (1990) Progression of cardiopathology in Friedreich ataxia: clinico-instrumental study. Cardiologia 35(5):423–431PubMed Casazza F, Ferrari F, Piccone U, Maggiolini S, Capozi A, Morpurgo M (1990) Progression of cardiopathology in Friedreich ataxia: clinico-instrumental study. Cardiologia 35(5):423–431PubMed
9.
Zurück zum Zitat Casazza F, Morpurgo M (1996) The varying evolution of Friedreich’s ataxia cardiomyopathy. Am J Cardiol 77(10):895–898PubMedCrossRef Casazza F, Morpurgo M (1996) The varying evolution of Friedreich’s ataxia cardiomyopathy. Am J Cardiol 77(10):895–898PubMedCrossRef
10.
Zurück zum Zitat Durr A, Cossee M, Agid Y et al (1996) Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 335(16):1169–1175PubMedCrossRef Durr A, Cossee M, Agid Y et al (1996) Clinical and genetic abnormalities in patients with Friedreich’s ataxia. N Engl J Med 335(16):1169–1175PubMedCrossRef
11.
Zurück zum Zitat Bit-Avragim N, Perrot A, Schols L et al (2001) The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich’s ataxia. J Mol Med 78(11):626–632PubMedCrossRef Bit-Avragim N, Perrot A, Schols L et al (2001) The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich’s ataxia. J Mol Med 78(11):626–632PubMedCrossRef
13.
Zurück zum Zitat Asaad NE-MA, Al Suwaidi J (2010) Recurrent ventricular tachycardia in patient with Friedreich’s ataxia in the absence of clinical myocardial disease. Pacing Clin Electrophysiol 33(1):109–112PubMedCrossRef Asaad NE-MA, Al Suwaidi J (2010) Recurrent ventricular tachycardia in patient with Friedreich’s ataxia in the absence of clinical myocardial disease. Pacing Clin Electrophysiol 33(1):109–112PubMedCrossRef
14.
Zurück zum Zitat Groh W (2004). In: Zipes DP, Jalife J (eds) Arrhythmias in patients with neurologic disorders, in cardiac electrophysiology: from cell to bedside. WB Saunders, Philadelphia, pp 640–650 Groh W (2004). In: Zipes DP, Jalife J (eds) Arrhythmias in patients with neurologic disorders, in cardiac electrophysiology: from cell to bedside. WB Saunders, Philadelphia, pp 640–650
15.
Zurück zum Zitat SP Giugliano GR (2007) Friedreich’s ataxia as a cause of premature coronary artery disease. Tex Heart Inst J 34(2):214–217 SP Giugliano GR (2007) Friedreich’s ataxia as a cause of premature coronary artery disease. Tex Heart Inst J 34(2):214–217
16.
Zurück zum Zitat Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ (1999) Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart 81(2):141–147PubMed Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ (1999) Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart 81(2):141–147PubMed
17.
Zurück zum Zitat Alboliras ET, Shub C, Gomez MR et al (1986) Spectrum of cardiac involvement in Friedreich’s ataxia: clinical, electrocardiographic and echocardiographic observations. Am J Cardiol 58(6):518–524PubMedCrossRef Alboliras ET, Shub C, Gomez MR et al (1986) Spectrum of cardiac involvement in Friedreich’s ataxia: clinical, electrocardiographic and echocardiographic observations. Am J Cardiol 58(6):518–524PubMedCrossRef
18.
19.
Zurück zum Zitat Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42(9):1687–1713PubMedCrossRef Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42(9):1687–1713PubMedCrossRef
20.
Zurück zum Zitat Jessup M, Abraham WT, Casey DE et al (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14):1977–2016PubMedCrossRef Jessup M, Abraham WT, Casey DE et al (2009) 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14):1977–2016PubMedCrossRef
21.
Zurück zum Zitat CM Sedlak TL, Straatman L (2004) Cardiac transplantation: a temporary solution for Friedreich’s ataxia-induced dilated cardiomyopathy. J Heart Lung Transplant 23:1304–1306CrossRef CM Sedlak TL, Straatman L (2004) Cardiac transplantation: a temporary solution for Friedreich’s ataxia-induced dilated cardiomyopathy. J Heart Lung Transplant 23:1304–1306CrossRef
22.
Zurück zum Zitat Segovia J A-PL, Burgos R, L. Silva, et al (2001) Heart transplantation in Friedreich’s ataxia and other neuromuscular diseases. J Heart Lung Transpl 20:169 Segovia J A-PL, Burgos R, L. Silva, et al (2001) Heart transplantation in Friedreich’s ataxia and other neuromuscular diseases. J Heart Lung Transpl 20:169
23.
Zurück zum Zitat E-BA Yoda M, Arusoglu L, Tendrich G, Minami K, Korfer R (2006) Permanent use of a ventricle assist device for dilated cardiomyopathy in Friedreich’s ataxia. J Heart Lung Transplant 25:251–252CrossRef E-BA Yoda M, Arusoglu L, Tendrich G, Minami K, Korfer R (2006) Permanent use of a ventricle assist device for dilated cardiomyopathy in Friedreich’s ataxia. J Heart Lung Transplant 25:251–252CrossRef
24.
Zurück zum Zitat Epstein AE, DiMarco JP, Ellenbogen KA et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the Surgeons. J Am Coll Cardiol 51(21):e1–e62PubMedCrossRef Epstein AE, DiMarco JP, Ellenbogen KA et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the Surgeons. J Am Coll Cardiol 51(21):e1–e62PubMedCrossRef
25.
Zurück zum Zitat Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48(5):e247–e346PubMedCrossRef Zipes DP, Camm AJ, Borggrefe M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48(5):e247–e346PubMedCrossRef
26.
Zurück zum Zitat Walker S, Levy T, Rex S, Paul VE (1999) Biventricular implantable cardioverter defibrillator use in a patient with heart failure and ventricular tachycardia secondary to Emery-Dreifuss syndrome. Europace 1(3):206–209PubMedCrossRef Walker S, Levy T, Rex S, Paul VE (1999) Biventricular implantable cardioverter defibrillator use in a patient with heart failure and ventricular tachycardia secondary to Emery-Dreifuss syndrome. Europace 1(3):206–209PubMedCrossRef
27.
Zurück zum Zitat Luethje LG, Boennemann C, Goldfarb L, Goebel HH, Halle M (2004) Prophylactic implantable cardioverter defibrillator placement in a sporadic desmin related myopathy and cardiomyopathy. Pacing Clin Electrophysiol 27(4):559–560PubMedCrossRef Luethje LG, Boennemann C, Goldfarb L, Goebel HH, Halle M (2004) Prophylactic implantable cardioverter defibrillator placement in a sporadic desmin related myopathy and cardiomyopathy. Pacing Clin Electrophysiol 27(4):559–560PubMedCrossRef
Metadaten
Titel
Friedreich’s Ataxia: a review from a cardiology perspective
verfasst von
T. Bourke
D. Keane
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 4/2011
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-011-0744-y

Weitere Artikel der Ausgabe 4/2011

Irish Journal of Medical Science (1971 -) 4/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.